A lot of people in the pharma industry know about Valeant, the company that’s been fighting the drug company’s battle to get generic drugs to market.That’s why, for the past two years, investors have been buying up Valeant stock like it was the hottest new commodity in the world.Valeant’s stock has been up more than […]

Continue Reading...